Skip to content

Anxiety research published in 2020

Page 2 of 8: studies 21 to 40 of 146, newest first. Back to the anxiety overview

Studies

Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT)

Journal of Psychoactive Drugs November 26, 2020 Heba Diab, Benjamin Malcolm 1 citation

This case report describes a 39-year-old male with remote history of polysubstance use disorder and depression who developed tinnitus after use of inhaled N,N-dimethyltryptamine (DMT). Although development of ear ringing was attributed to use on a single occasion, tinnitus occurred within the context of a larger self-experiment involving weekly microdoses of lysergic acid diethylamide (LSD)....

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study

Scientific Reports November 24, 2020 Julane Andries, Lisa Jerome, Evan Sola et al. 170 citations

Abstract The success of modern medicine creates a growing population of those suffering from life-threatening illnesses (LTI) who often experience anxiety, depression, and existential distress. We present a novel approach; investigating MDMA-assisted psychotherapy for the treatment of anxiety in people with an LTI. Participants with anxiety from an LTI were randomized in a double-blind study to...

Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant

Journal of Affective Disorders November 14, 2020 Stacie Hudgens, Lysbeth Floden, Michael Blackowicz et al. 77 citations

Patients with major depressive disorder who do not respond to ≥2 different pharmacological treatments within the current depressive episode are considered to have treatment resistant depression (TRD). This analysis determined meaningful change thresholds (MCT) of the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) using anchor-based methods and...

DOI: 10.1016/j.jad.2020.11.066 (opens in new tab) Anxiety Depression economics Patient health questionnaire Rating scale +4

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L’humeur Et De L’anxiété (Canmat) Concernant L’utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur

The Canadian Journal of Psychiatry November 11, 2020 Jennifer Swainson, Alexander McGirr, Pierre Blier et al. 109 citations

OBJECTIVE: -methyl-d-aspartate (NMDA) receptor antagonist, has demonstrated rapid antidepressant effects in patients with TRD. The Canadian Network for Mood and Anxiety Treatments (CANMAT) convened a task force to review the evidence for efficacy and safety of racemic ketamine and to provide recommendations for its use in clinical practice. METHODS: A systematic review was conducted with...

Generalized Anxiety Disorder Symptom Improvement Following Mindfulness-Based Stress Reduction in a General Hospital Setting

Journal of Medical Psychology November 6, 2020 Holly Hazlett-Stevens

Background: GAD symptom complaints are common in general medical settings, yet psychosocial intervention options provided within such settings are limited. Randomized controlled trials have found that MBSR is effective for symptom reduction, but such research typically delivered MBSR to small diagnostically homogeneous patient groups rather than to larger heterogeneous groups as provided in...

Freedom of the Singing Voice: An Exploration of the Mind-Body Connection, Performance Anxiety and Confidence through Methods of Fitzmaurice Voicework, Organic Intelligence, and Ziva Meditation

November 5, 2020 Lydia Flock

ABSTRACT The psychological aspect of elite performance is increasingly recognized. Indeed, many elite athletes and sportspeople employ psychological techniques within their practice to reduce excess physical tension and feelings of performance anxiety. However, similar practices are less often part of standard singing training. Therefore, this study aimed to integrate mindfulness and wellbeing...

Mindfulness-Based Programs Improve Psychological Flexibility, Mental Health, Well-Being, and Time Management in Academics

European Journal of Investigation in Health, Psychology and Education November 3, 2020 Gabriel Marais, Sophie Lantheaume, Robin Fiault et al. 51 citations

(1) Background: Occupational stress is high in academia, and is partly related to time pressure. Mindfulness-based programs are known to be effective in reducing stress and increasing well-being. Recent work suggested that these programs may also improve time management. This study tested the effects of a mindfulness-based program on academics' psychological flexibility, mental health,...

Efficacy of Mindfulness Based Cognitive Therapy on Children With Anxiety.

Journal of Cognitive Psychotherapy November 1, 2020 Rima Shetty, Sreejayan Kongasseri, Shweta Rai

This study examined the efficacy of mindfulness based cognitive therapy on children (MBCT-C) with anxiety. Two hundred and forty children were screened, of which 52 (25 boys and 27 girls) with anxiety were randomly allocated to either MBCT-C or group therapy (GT including cognitive behavioral principles). Both groups were rated on the Spence Children's Anxiety Scale and Emotion Regulation...

A Narrative Study of the Five Senses Meditation of the Adolescent Suffering from Abandonment Anxiety

October 31, 2020 Kyung-Min Ahn

This study aimed to investigate on the effect of the Five Senses Meditation to an adolescent suffering from abandonment anxiety. The subject of the study is a student attending a high school in P-city and has an experience of being raised by several foster parents from childhood. This study focused on searching for the root and context of the pain by facing, discerning, and accepting...

Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects

Brazilian Journal of Psychiatry October 30, 2020 Ícaro Durante, Rafael G. Dos Santos, José Carlos Bouso et al. 49 citations

A minority of participants reported being very negatively affected by persistent adverse effects. Psychiatric medication use while participating in ayahuasca rituals was not associated with increased adverse effects. For the most part, the institution's practices seem sufficient to prevent exacerbated reactions. Future studies may focus on negatively affected users.

Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies

Acta Psychiatrica Scandinavica October 30, 2020 Kristoffer Andreas Aamodt Andersen, Robin Carhart-Harris, David Nutt et al. 352 citations

Abstract Objective To conduct a systematic review of modern‐era (post‐millennium) clinical studies assessing the therapeutic effects of serotonergic psychedelics drugs for mental health conditions. Although the main focus was on efficacy and safety, study characteristics, duration of antidepressants effects across studies, and the role of the subjective drug experiences were also reviewed and...

Out of Body, Loss of Self: Spiritual or Scary?

Religions October 29, 2020 Elpine M. de Boer

The main aim of the present study is to investigate when “loss of self” results in scaredness or anxiety during or after an out-of body-experience (OBE). An OBE is an intense form of (bodily) self loss in which people have the impression that their self is located outside their body. In a sample of respondents reporting to have had an OBE (n = 171), anxiety and different conceptualizations of...

Candidate Strategies for Development of a Rapid-Acting Antidepressant Class That Does Not Result in Neuropsychiatric Adverse Effects: Prevention of Ketamine-Induced Neuropsychiatric Adverse Reactions

International Journal of Molecular Sciences October 26, 2020 Motohiro Okada, Yasuhiro Kawano, Kouji Fukuyama et al. 31 citations

Non-competitive N-methyl-D-aspartate/glutamate receptor (NMDAR) antagonism has been considered to play important roles in the pathophysiology of schizophrenia. In spite of severe neuropsychiatric adverse effects, esketamine (racemic enantiomer of ketamine) has been approved for the treatment of conventional monoaminergic antidepressant-resistant depression. Furthermore, ketamine improves...

Treatment of a Complex Personality Disorder Using Repeated Doses of LSD—A Case Report on Significant Improvements in the Absence of Acute Drug Effects

Frontiers in Psychiatry October 22, 2020 Felix Müller, Markus Mühlhauser, Friederike Holze et al. 31 citations

A 39-year-old female patient suffering from severe, treatment-resistant depression and other symptoms associated with a complex personality disorder was admitted to our open psychiatric ward for an experimental treatment with lysergic acid diethylamide (LSD). The substance was administered in repeated weekly and ascending doses. Curiously, there were no substantial acute subjective effects of...

Mindfulness-based cognitive therapy on bereavement grief: Alterations of resting-state network connectivity associate with changes of anxiety and mindfulness.

Human Brain Mapping October 17, 2020 Feng-Ying Huang, Ai-Ling Hsu, Yi-Ping Chao et al.

Bereavement, the experience of losing a loved one, is one of the most catastrophic but inevitable events in life. It causes grief and intense depression-like sadness. Recent studies have revealed the effectiveness and proficiency of mindfulness-based cognitive therapy (MBCT) in emotional regulation among bereavement populations. MBCT improves the well-being of the bereaved by enhancing...

Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study

European Neuropsychopharmacology October 17, 2020 Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder et al. 121 citations

There is a popular interest in microdosing with psychedelics such as LSD. This practice of using one-tenth of a full psychedelic dose according to a specific dosing schedule, anecdotally enhances mood and performance. Nonetheless, controlled research on the efficacy of microdosing is scarce. The main objective of the present dose-finding study was to determine the minimal dose of LSD needed to...

DOI: 10.1016/j.euroneuro.2020.10.002 (opens in new tab) Anxiety Mood Vigilance psychology Cognition +7

The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence

Journal of Psychopharmacology October 11, 2020 Roger S McIntyre, Nelson B Rodrigues, Orly Lipsitz et al. 19 citations

Background: Individuals meeting criteria for treatment-resistant depression (TRD) are differentially affected by high levels of anxiety symptoms. Aims: There is a need to identify the efficacy of novel rapid-onset treatments in adults with mood disorders and comorbid anxious-distress. Methods: This study included patients with treatment-resistant major depressive disorder (MDD) or bipolar...

Randomized controlled trial of a group intervention combining self-hypnosis and self-care: secondary results on self-esteem, emotional distress and regulation, and mindfulness in post-treatment cancer patients

Quality of Life Research October 6, 2020 Charlotte Grégoire, Marie-Elisabeth Faymonville, Audrey Vanhaudenhuyse et al. 25 citations

PURPOSE: Cancer patients often report low self-esteem and high emotional distress. Two factors seem particularly linked to these symptoms: emotion regulation strategies and mindfulness. The interest of hypnosis and self-care to relieve these symptoms is not well documented. Our randomized controlled trial aimed at assessing the effect of a group intervention combining self-hypnosis and...

Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties

Journal of Translational Medicine October 2, 2020 Lara Sharpe, Justin Sinclair, Andrew Kramer et al. 122 citations

BACKGROUND: -tetrahydrocannabinol (THC) has been associated with an anxiogenic response, while anxiolytic activity has been attributed mainly to cannabidiol (CBD). In animal studies, the effects of THC are highly dose-dependent, and biphasic effects of cannabinoids on anxiety-related responses have been extensively documented. A more precise assessment is required of both the anxiolytic and...

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression

Neuropsychiatric Disease and Treatment October 1, 2020 Joanna Szarmach, Wiesław Jerzy Cubała, Adam Włodarczyk et al. 15 citations

INTRODUCTION: Ketamine exhibits antidepressant properties in treatment-resistant depression (TRD) with some concern over its cardiovascular safety and tolerability issues. This paper reports on the cardiovascular safety in short-term intravenous ketamine treatment in TRD inpatients with major depressive disorder (MDD) and bipolar disorder (BP). MATERIALS AND METHODS: The observational study...